Privia Health Group, INC Form 4 insider transactions

Director Thomas A. McCarthy reports acquisition of 10,000 shares and receipt of 11,124 restricted stock units of Privia Health Group, Inc.

Director Pamela Kimmet reported the acquisition of 11,124 restricted stock units in Privia Health Group, Inc. on May 22, 2024.

Director Jaewon Ryu reports acquisition of restricted stock units and disposal of common stock in Privia Health Group, Inc.

Director Adam Boehler indirectly acquired Privia Health Group shares through Puma Growth Holdings in multiple transactions, increasing his beneficial ownership.

Director William M. Sullivan reports acquisition of restricted stock units and disposal of common stock.

David S. Wichmann, a director at Privia Health Group, received 11,124 restricted stock units on May 22, 2024, under the company's 2021 Omnibus Incentive Plan.

Director Nancy Cocozza reports acquisition of 11,124 restricted stock units in Privia Health Group, Inc.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, sold 2,232 shares of common stock on May 10, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Thomas Bartrum, former EVP and General Counsel of Privia Health Group, Inc., sold 1,506 shares of common stock on May 10, 2024, to cover tax withholding obligations related to the vesting and settlement of restricted stock units.

Privia Health Group's CEO, Parth Mehrotra, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, sold 2,320 shares of common stock on April 30, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Thomas Bartrum, former EVP and General Counsel of Privia Health Group, Inc., reports the sale of 2,252 shares of common stock to cover tax withholding obligations.

Privia Health Group's CEO, Parth Mehrotra, sold shares to cover tax obligations related to the vesting of restricted stock units.

Matthew Shawn Morris, a director at Privia Health Group, sold 11,059 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, sold shares to cover tax obligations related to vesting restricted stock units.

EVP and Chief Financial Officer of Privia Health Group, David Mountcastle, reports the acquisition of restricted stock units and a disposition of common stock.

Privia Health Group's CEO, Parth Mehrotra, acquired 119,885 shares of common stock through restricted stock units, increasing his total holdings.

Edward C. Fargis, EVP & General Counsel of Privia Health Group, reports the acquisition of 28,544 restricted stock units.

Director William M. Sullivan sold shares of Privia Health Group, Inc. on March 8 and March 11, 2024, under a pre-arranged trading plan.